The antiviral activity of remdesivir, an investigational treatment for COVID-19, may potentially be reduced if it is coadministered with chloroquine or hydroxychloroquine, according to the FDA.
The FDA has revoked the emergency use authorization for chloroquine phosphate and hydroxychloroquine sulfate based on emerging data suggesting that these agents are unlikely to be effective against COVID-19.
A partnership that would bypass the drug industry to sell a potential vaccine against the new coronavirus has been formed.
Prescription fill patterns of medications associated with potential benefits, as well as possible harms, during the COVID-19 pandemic described in new analysis.
In 2018, half of US hospitals had the capacity to conduct telehealth-based outpatient visits, while only 1 in 4 had tele-ICU capabilities.
In a special article from the American College of Physicians, practice points are presented to guide the use of chloroquine or hydroxychloroquine in the setting of COVID-19.
The ACR released for re-engagement of routine radiology care during the COVID-19 pandemic.
A deal for hundreds of millions of syringes that could be used to quickly administer a possible vaccine against COVID-19 has been reached between the US government and a private company.
Haymarket Medical Network, a part of business media company Haymarket Media, Inc., is proud to join the Ad Council’s first ever Private Marketplace (PMP) along with other partners Cadreon, The Trade Desk and Acxiom.
Professional societies issue stern warning not to inappropriately prescribe or stockpile medications for COVID-19.